Mylan NV
MYL
Delayed Nasdaq - 01/17 04:05:08 pm
46.7USD
+0.13%
Prev.46.6400
Open46.4500
High46.8800
Low46.3700
Volume393 999
Last news
Financials
Sales 2017 11 988 M
EBIT 2017 3 405 M
R. net 2017 846 M
Debt 2017 13 869 M
Rend. 2017 -
P/E ratio 2017 24,63
P/E ratio 2018 16,80
EV / Sales 2017 3,24x
EV / Sales 2018 2,89x
Capitalization 25 012 M
Company
Mylan N.V., is a pharmaceutical company which engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products.The company was founded on July 7, 2014 and is headquartered in Hatfield, United Kingdom.
Sector :
Pharmaceuticals - NEC
Calendar :
2018-02-28 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance46,946,946,9
Spread/Res.-0,43%-0,43%-0,43%
Spread/Supp.12%28%25%
Support41,936,537,4